Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 2, 2021 21:07 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,218 | $212.42 | $471,147.56 |
DisclosureSEC source: 0001209191-21-015849 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,666 Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:03 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 354 | $216.26 | $76,556.04 |
DisclosureSEC source: 0001209191-21-014679 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,589 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:03 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 680 | $214.28 | $145,710.40 |
DisclosureSEC source: 0001209191-21-014679 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,943 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:03 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,348 | $213.05 | $287,191.40 |
DisclosureSEC source: 0001209191-21-014679 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,623 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $213.05 (range $212.76 to $213.68). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:03 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 646 | $211.58 | $136,680.68 |
DisclosureSEC source: 0001209191-21-014679 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,971 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 254 | $216.57 | $55,008.78 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,103 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $216.57 (range $216.50 to $216.62). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 300 | $215.62 | $64,686.00 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 6 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,357 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $215.62 (range $215.37 to $215.84). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 400 | $214.32 | $85,728.00 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,657 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $214.32 (range $214.10 to $214.62). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,400 | $213.55 | $298,970.00 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,057 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $213.55 (range $213.09 to $214.08). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 900 | $212.52 | $191,268.00 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,457 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $212.52 (range $212.05 to $213.02). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 380 | $211.39 | $80,328.20 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,357 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $211.39 (range $210.76 to $211.68). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 354 | $216.26 | $76,556.04 |
DisclosureSEC source: 0001209191-21-014736 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,837 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 680 | $214.28 | $145,710.40 |
DisclosureSEC source: 0001209191-21-014736 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,191 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 1,348 | $213.04 | $287,177.92 |
DisclosureSEC source: 0001209191-21-014736 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,871 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $213.04 (range $212.76 to $213.68). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 646 | $211.58 | $136,680.68 |
DisclosureSEC source: 0001209191-21-014736 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,219 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 200 | $216.62 | $43,324.00 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,133 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 336 | $215.56 | $72,428.16 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,333 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $215.56 (range $215.12 to $215.85). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 668 | $214.19 | $143,078.92 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,669 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $214.19 (range $213.94 to $214.78). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 1,460 | $213.30 | $311,418.00 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,337 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $213.30 (range $212.93 to $213.88). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 922 | $211.56 | $195,058.32 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,797 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $211.56 (range $211.06 to $211.87). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:23 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
SaleCommon Stock | 126 | $216.25 | $27,247.50 |
DisclosureSEC source: 0001209191-21-014749 · doc4.xml · nonDerivative · entry 5 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,884 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $216.25 (range $215.79 to $216.76). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:23 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
SaleCommon Stock | 258 | $214.32 | $55,294.56 |
DisclosureSEC source: 0001209191-21-014749 · doc4.xml · nonDerivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,010 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $214.32 (range $213.90 to $214.69). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:23 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
SaleCommon Stock | 452 | $213.12 | $96,330.24 |
DisclosureSEC source: 0001209191-21-014749 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,268 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.82 to $213.79). Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:23 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
SaleCommon Stock | 244 | $211.80 | $51,679.20 |
DisclosureSEC source: 0001209191-21-014749 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,720 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $211.80 (range $211.57 to $212.07). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:03 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Tax withholdingCommon Stock | 2,416 | $217.57 | $525,649.12 |
DisclosureSEC source: 0001209191-21-014679 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,617 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:07 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,898 | $217.57 | $630,517.86 |
DisclosureSEC source: 0001209191-21-014690 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,737 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:12 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 311 | $217.57 | $67,664.27 |
DisclosureSEC source: 0001209191-21-014713 · doc4.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,264 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:15 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 2,898 | $217.57 | $630,517.86 |
DisclosureSEC source: 0001209191-21-014723 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,643 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
Tax withholdingCommon Stock | 2,416 | $217.57 | $525,649.12 |
DisclosureSEC source: 0001209191-21-014736 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,865 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Tax withholdingCommon Stock | 2,946 | $217.57 | $640,961.22 |
DisclosureSEC source: 0001209191-21-014743 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,719 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:23 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 864 | $217.57 | $187,980.48 |
DisclosureSEC source: 0001209191-21-014749 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,964 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:26 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 1,036 | $217.57 | $225,402.52 |
DisclosureSEC source: 0001209191-21-014752 · doc4.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,432 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:29 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 547 | $217.57 | $119,010.79 |
DisclosureSEC source: 0001209191-21-014759 · doc4.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,226 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:05 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 200 | $213.26 | $42,652.00 |
DisclosureSEC source: 0001209191-21-012320 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,033 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $213.26 (range $213.23 to $213.29). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:05 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 2,033 | $212.59 | $432,195.47 |
DisclosureSEC source: 0001209191-21-012320 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,233 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $212.59 (range $212.22 to $213.00). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:05 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 4,513 | $211.84 | $956,033.92 |
DisclosureSEC source: 0001209191-21-012320 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,266 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $211.84 (range $211.22 to $212.21). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:05 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,079 | $210.11 | $226,708.69 |
DisclosureSEC source: 0001209191-21-012320 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,779 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $210.11 (range $209.60 to $210.54). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $213.26 | $21,326.00 |
DisclosureSEC source: 0001209191-21-012328 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,635 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $213.26 (range $213.23 to $213.29). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,763 | $212.49 | $587,109.87 |
DisclosureSEC source: 0001209191-21-012328 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,735 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $212.49 (range $212.15 to $213.04). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,940 | $211.77 | $834,373.80 |
DisclosureSEC source: 0001209191-21-012328 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,498 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $211.77 (range $211.15 to $212.14). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,022 | $210.05 | $214,671.10 |
DisclosureSEC source: 0001209191-21-012328 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,438 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $210.05 (range $209.63 to $210.52). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 200 | $213.45 | $42,690.00 |
DisclosureSEC source: 0001209191-21-012347 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,281 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $213.45 (range $213.30 to $213.68). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 1,952 | $212.56 | $414,917.12 |
DisclosureSEC source: 0001209191-21-012347 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,481 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $212.56 (range $212.25 to $212.95). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 4,666 | $211.83 | $988,398.78 |
DisclosureSEC source: 0001209191-21-012347 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,433 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $211.83 (range $211.25 to $212.24). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:18 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 1,007 | $210.08 | $211,550.56 |
DisclosureSEC source: 0001209191-21-012347 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,099 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $210.08 (range $209.60 to $210.54). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 800 | $213.02 | $170,416.00 |
DisclosureSEC source: 0001209191-21-012352 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,665 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $213.02 (range $212.74 to $213.33). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 5,800 | $212.15 | $1,230,470.00 |
DisclosureSEC source: 0001209191-21-012352 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,465 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $212.15 (range $211.74 to $212.70). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 1,500 | $211.36 | $317,040.00 |
DisclosureSEC source: 0001209191-21-012352 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,265 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $211.36 (range $210.74 to $211.64). Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:20 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 1,164 | $210.00 | $244,440.00 |
DisclosureSEC source: 0001209191-21-012352 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,765 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $210.00 (range $209.61 to $210.34). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:21 UTC |
Silva Paul MSVP & Chief Accounting Officer
|
SaleCommon Stock | 1,368 | $212.62 | $290,864.16 |
DisclosureSEC source: 0001209191-21-012355 · doc4.xml · nonDerivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,828 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $212.62 (range $212.15 to $213.14). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.